Irish women with breast cancer invited to take part in new clinical trial at DCU

Irish women with HER2-positive breast cancer are invited to take part in a clinical trial in DCU’s National Institute of Cellular Biotechnology. This trial might yield some interesting results. To find out more information click the link below:


Share This Article